Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism

Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism

Context. Esaxerenone is a new mineralocorticoid receptor antagonist (MRA). It is an oral nonsteroidal MRA with high MR-binding specificity and antihypertensive effects in patients with essential hypertension and primary aldosteronism (PA). This study aimed to investigate the underlying characteristi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Masanori Fujimoto, Suzuka Watanabe, Katsushi Igarashi, Yutaro Ruike, Kazuki Ishiwata, Kumiko Naito, Akiko Ishida, Masaya Koshizaka, Sawako Suzuki, Yuki Shiko, Hisashi Koide, Koutaro Yokote
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	International Journal of Hypertension
Online Access:	http://dx.doi.org/10.1155/2023/6453933
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights
by: Takumi Kitamoto, et al.
Published: (2025-01-01)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
by: Yoko Takatsuna, et al.
Published: (2020-01-01)

Esaxerenone improves the blood pressure and metabolic parameters of hypertensive subjects with diabetes
by: Saki Kuwabara, et al.
Published: (2025-08-01)

A Prospective Crossover Clinical Trial of Esaxerenone and Eplerenone in Patients with Chronic Heart Failure Complicated by Hypertension
by: Akira Sezai, et al.
Published: (2025-05-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
by: S. V. Stolov
Published: (2020-12-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

Unmasked acute intermittent porphyria in a patient with COVID-19-associated posterior reversible encephalopathy syndrome
by: Hideo Handa, et al.
Published: (2025-04-01)

WCN24-1326 ANTIHYPERTENSIVE TREATMENT AND SODIUM CONSUMPTION AS CONFOUNDING FACTORS IN THE ALDOSTERONE-RENIN RATIO, RENIN, AND ALDOSTERONE LEVELS IN AFRO-COLOMBIAN APPARENT RESISTANT HYPERTENSIVE PATIENTS: A PRI
by: Carlos Duran, et al.
Published: (2024-04-01)

Impact of Renin–Angiotensin–Aldosterone System (RAAS) Gene Polymorphism in Essential Hypertension and Antihypertensive Drug Therapy: A Review
by: Archana Adhikari, et al.
Published: (2025-01-01)

The association between aldosterone and lipid profiles in patients with primary aldosteronism
by: Ning-Peng Liang, et al.
Published: (2025-03-01)

Effect of Age on Aldosterone–Renin Ratio in Screening Primary Aldosteronism
by: Ning Peng, et al.
Published: (2025-03-01)

Effect of C-344T polymorphism of aldosterone synthase gene on variability of antihypertensive therapy with angiotensin II receptor blockers: open randomized controlled clinical trial
by: E. V. Rebrova, et al.
Published: (2024-11-01)

Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment
by: Eriko Nakano, et al.
Published: (2025-07-01)

Arterial hypertension and aldosterone
by: V. N. Titov
Published: (2007-12-01)

Occurrence of Metabolic Disorders in Bilateral Primary Aldosteronism Compared to Unilateral Primary Aldosteronism
by: Chiara Grasselli, et al.
Published: (2025-02-01)

Histopathological spectrum of common aldosterone-driver gene mutations in aldosterone-producing adenomas
by: Fatin Athirah Pauzi, et al.
Published: (2025-06-01)

Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening
by: Linqiang Ma, et al.
Published: (2018-01-01)

Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01)

Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications
by: Chia-Hui Chang, et al.
Published: (2018-01-01)

Myocardial fibrosis in primary aldosteronism
by: Yi-Lin Chen, et al.
Published: (2025-05-01)

Diagnostic uncertainty in primary aldosteronism
by: Marković Bojan, et al.
Published: (2024-01-01)

The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism
by: Jing Xu, et al.
Published: (2020-01-01)

EGR1 regulates oxidative stress and aldosterone production in adrenal cells and aldosterone-producing adenomas
by: Yingxian Pang, et al.
Published: (2025-03-01)

Measurement accuracy and cutoffs for predicting primary aldosteronism diagnosis using Lumipulse® for renin and aldosterone measurements.
by: Maude Laney, et al.
Published: (2025-01-01)

High Efficiency and Problems of Chemiluminescence Assay-Detected Aldosterone-To-Renin Ratio in Practical Primary Aldosteronism Screening
by: Wenbin Lin, et al.
Published: (2020-01-01)

Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor
by: Miyeon Kim, et al.
Published: (2025-05-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

Treatment of Primary Aldosteronism and Organ Protection
by: Cristiana Catena, et al.
Published: (2015-01-01)

Determinants of serum aldosterone in Kemerovo Region
by: B. A. Tkhorenko, et al.
Published: (2020-09-01)

A Normotensive Patient with Primary Aldosteronism
by: Xiao Lin, et al.
Published: (2017-01-01)

Evidence for Aldosterone Antagonism in Heart Failure
by: Rishi Sethi, et al.
Published: (2024-11-01)

Aldosterone in the brain and cognition: knowns and unknowns
by: Anna Nieckarz, et al.
Published: (2024-11-01)

Intratumoural aldosterone and CYP11B2 expression levels among different genotypes of aldosterone producing tumours
by: Tobias Åkerström, et al.
Published: (2025-06-01)

Diagnostic efficacy of aldosterone-to-renin ratio to screen primary aldosteronism in hypertension: a systemic review and meta-analysis
by: Ting-Wei Kao, et al.
Published: (2024-12-01)

Blood pressure categorization and subclinical left ventricular dysfunction in antihypertensive medication‐naive subjects
by: Koki Nakanishi, et al.
Published: (2022-06-01)

Association of serum cortisol with insulin secretion and plasma aldosterone with insulin resistance in untreated type 2 diabetes: a cross-sectional study
by: Masahiro Ohira, et al.
Published: (2025-04-01)

Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
by: Naohisa Tamura, et al.
Published: (2021-01-01)

Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome‐Wide Association and Mendelian Randomization Study
by: Kosuke Inoue, et al.
Published: (2024-08-01)

ALDOSTERONE AND OBESITY: WHERE TO LOOK FOR THE KEY TO THERAPY?
by: N. T. Vatutin, et al.
Published: (2016-08-01)

Pathology and gene mutations of aldosterone-producing lesions
by: Koshiro Nishimoto, et al.
Published: (2023-12-01)